Press Release: European Medicines Agency recommends authorisation of novel antibiotic agent

Author (Corporate)
Series Title
Series Details EMA/CHMP/757738/2011 (23.9.11)
Publication Date 23/09/2011
Content Type

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in September 2011, recommended the authorisation of the first antibiotic in a new class to treat infections with Clostridium difficile. The CHMP’s opinion represents a major step forward by providing a new medicine to tackle the growing levels of resistance to available antibiotics across the European Union.
Source Link Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/09/news_detail_001349.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/CHMP/757738/2011 (23.9.11) http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2011/09/WC500112848.pdf
Subject Categories
Countries / Regions